Viking Therapeutics, Inc.(VKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VKTX Viking Therapeutics, Inc.

盘前交易 07-22 05:33:49 EDT

50.90

+0.80

+1.60%

最高52.34	最低49.75	成交量188.56万
今开49.94	昨收50.10	日振幅5.17%
总市值56.13亿	流通市值53.12亿	总股本1.10亿
成交额9,624万	换手率1.81%	流通股本1.04亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VKTX","market":"US","secType":"STK","nameCN":"Viking Therapeutics, Inc.","latestPrice":50.9,"timestamp":1721419200000,"preClose":50.1,"halted":0,"volume":1885594,"delay":0,"floatShares":104358925,"shares":110268210,"eps":-0.931394,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.8,"latestTime":"07-22 05:33:49 EDT","open":49.94,"high":52.3399,"low":49.75,"amount":96237979.877512,"amplitude":0.051695,"askPrice":51.15,"askSize":1,"bidPrice":50.5,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.931394,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1430280000000,"adjPreClose":50.9,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":51,"preClose":50.9,"latestTime":"19:52 EDT","volume":72484,"amount":3689947.7091,"timestamp":1721433144601},"volumeRatio":0.6178241607605367,"impliedVol":1.1616,"impliedVolPercentile":0.776},"requestUrl":"/m/hq/s/VKTX/tweets","defaultTab":"tweets","newsList":[{"id":"2452861160","title":"BUZZ-罗氏试验性药物的早期数据令肥胖药生产商望而却步","url":"https://stock-news.laohu8.com/highlight/detail?id=2452861160","media":"Reuters","labels":["Business Data"],"top":-1,"share":"https://www.laohu8.com/m/news/2452861160?lang=zh_cn&edition=full","pubTime":"2024-07-18 01:11","pubTimestamp":1721236299,"startTime":"0","endTime":"0","summary":"** 瑞士制药商罗氏  报告了一种试验性每日一次肥胖药CT-996的早期数据 ，该药帮助 患者在四周内平均减轻了6.1%的体重。** Structure 公司的口服肥胖症药物在一项中期研究中帮助患者平均减轻了 6.2% 的体重，而 VKTX 公司预计将于今年开始对其片剂进行中期研究。** 经纪公司 BMO Capital 称，虽然罗氏的早期数据似乎与 GPCR 和 LLY 的实验药物相当，但要进行有意义的比较，还需要详细的耐受性数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","LU0820561818.USD","LU0640476718.USD","LU0094547139.USD","LU0456855351.SGD","IE00B2B36J28.USD","BK4516","BK4581","BK4533","LU0238689110.USD","IE00B4R5TH58.HKD","GPCR","LU0061475181.USD","IE00BK4W5M84.HKD","LU0320765059.SGD","LU0466842654.USD","VKTX","BK4534","LU0109391861.USD","BUZZ","LU1035775433.USD","LLY","LU0256863902.USD","LU0058720904.USD","LU0198837287.USD","LU0385154629.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU1267930730.SGD","IE00BK4W5L77.USD","LU0417517546.SGD","BK4007","LU0823416689.USD","LU1712237335.SGD","LU1057294990.SGD","LU0122379950.USD","LU0097036916.USD","LU0471298777.SGD","LU0672654240.SGD","LU0289739699.SGD","LU0689472784.USD","LU1064131342.USD","LU0882574139.USD","LU1023059063.AUD","LU1069344957.HKD","LU0820561909.HKD","IE00BJT1NW94.SGD","LU0708995401.HKD","IE00B1BXHZ80.USD","LU1623119135.USD"],"gpt_icon":1},{"id":"1167017119","title":"罗氏口服减肥药临床试验取得积极结果！减肥药概念股闻讯下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=1167017119","media":"老虎资讯综合","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/1167017119?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:41","pubTimestamp":1721223718,"startTime":"0","endTime":"0","summary":"7月17日，罗氏控股涨近8%，公司称其口服减肥药临床试验取得积极结果；受此消息影响，$诺和诺德(NVO)$、$礼来(LLY)$、Viking减肥药概念股集体下挫。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1804176565.USD","LU0471298694.HKD","BK4585","RHHBY","VKTX","LU0689472784.USD","LU0097036916.USD","IE00BK4W5M84.HKD","BK4534","LU0096364046.USD","LU0882574055.USD","BK4532","LLY","LU0466842654.USD","IE00BJLML261.HKD","LU0122379950.USD","LU0820561909.HKD","IE00B1BXHZ80.USD","IE00BK4W5L77.USD","NVO","LU1061106388.HKD"],"gpt_icon":0},{"id":"2452152264","title":"Viking Therapeutics, Inc.盘中异动 股价大跌5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452152264","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452152264?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:30","pubTimestamp":1721223023,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日21时30分，Viking Therapeutics, Inc.股票出现波动，股价急速下挫5.81%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Aditxt, Inc.、Longeveron Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Aditxt, Inc.、Aptevo Therapeutics Inc.、Longeveron Inc.较为活跃，换手率分别为616.00%、435.78%、90.98%，振幅较大的相关个股有Aditxt, Inc.、Terns Pharmaceuticals, Inc.、Kazia Therapeutics Limited，振幅分别为6.88%、4.64%、4.37%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213023aefa250f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717213023aefa250f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","LENZ","BK4588","VKTX"],"gpt_icon":0},{"id":"2452151905","title":"“诺礼”惊出一身冷汗！罗氏口服减肥药临床试验取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2452151905","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452151905?lang=zh_cn&edition=full","pubTime":"2024-07-17 21:20","pubTimestamp":1721222413,"startTime":"0","endTime":"0","summary":"罗氏旗下Genentech表示，其口服GLP-1受体激动剂CT-996在1期临床试验中的四周内平均体重减轻了约6%。","market":"sg","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1152309.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"“诺礼”惊出一身冷汗！罗氏口服减肥药临床试验取得积极结果","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["VKTX","BK4007","NVO","BK1141","BK1583","LLY","BK1576"],"gpt_icon":0},{"id":"2450357518","title":"BUZZ-辉瑞推进减肥药开发的举动拖累了一些药品开发商","url":"https://stock-news.laohu8.com/highlight/detail?id=2450357518","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450357518?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:07","pubTimestamp":1720703263,"startTime":"0","endTime":"0","summary":" (更新)    7月11日 - ** 减肥药开发商Viking Therapeutics   股价盘前下跌4.3%至55.50美元** 辉瑞  计划在今年下半年将其实验性肥胖药danuglipron的改良版、每日一次版推进到临床试验中。** 丹麦公司 Zealand Pharma A/S    下跌 4.5% ** 基于其减肥药物在  早期的积极数据，Zealand 预计将在 2024 年下半年启动一项中期试验** Altimmune  和Structure Therapeutics  的股价在收盘前小幅下跌** ALT和GPCR的肥胖症实验药物均已成功完成  中期试验 ** 截至上次收盘，VKTX的股价上涨了两倍多，ZELA上涨了一倍多，ALT下跌了33.5%，GPCR上涨了2.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","LU0868494617.USD","VKTX","BK4585","LU1066053197.SGD","SGXZ57979304.SGD","BK4007","BUZZ","BK4533","IE00B19Z3B42.SGD","LU0122379950.USD","IE00BLSP4239.USD","BK4534","BK4568","BK4588","IE00BBT3K403.USD","LU1894683348.USD","SG9999001176.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU1883839398.USD","LU1878469433.USD","IE00BLSP4452.SGD","LU0456855351.SGD","LU0170899867.USD","ALT","BK4592","SG9999011175.SGD","LU0321505868.SGD","LU1066051498.USD","LU1023059063.AUD","PFE","BK4550","LU0289739699.SGD","SG9999003800.SGD","LU0058720904.USD","LU0234572021.USD","LU0321505439.SGD","SG9999001176.USD","BK4581","LU1894683264.USD","LU1057294990.SGD","SG9999002224.SGD","SG9999013999.USD","BK4139","SG9999002232.USD"],"gpt_icon":0},{"id":"2450351338","title":"BUZZ--美国股票走势-好市多、百事可乐、美国铝业公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2450351338","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450351338?lang=zh_cn&edition=full","pubTime":"2024-07-11 20:20","pubTimestamp":1720700453,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      7月11日 - 美国股指期货周四下滑，原因是市场预期一项关键的通胀数据可能会影响减持押注，并使华尔街破纪录的上涨势头受到考验，而达美航空在发布疲软的业绩预测后出现下滑，拖累了其他航空股。** 贝克休斯  ：盘前上涨1.0** 越洋  ：盘前上涨0.8%BUZZZ - Susquehanna预计国际需求将在第二季度帮助油田服务公司，因为美国保持持平","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFMHRM44.USD","PEP","LU1668664300.SGD","LU0072461881.USD","CORZ","LU0456855351.SGD","LU1489326972.SGD","LU0251142724.SGD","COST","LU0130102774.USD","LU0154245756.USD","LU0130517989.USD","AA","VKTX","BK4177","QS","BUZZ","WYNN","LU1162221912.USD","LU0048573561.USD","LU0077335932.USD","IE00B3T34201.USD","BK4116","LU1496350171.SGD","PFE","IE00BKVL7J92.USD","LU0385154629.USD","LU1244550577.SGD","LU0128525689.USD","LU2095319765.USD","SLB","BK4179","LU1366192091.USD","DASH","SG9999004303.SGD","LU0742534661.SGD","LU1883839398.USD","LU2023250843.SGD","LU0471298777.SGD","LU0098860793.USD","LU2210150020.SGD","LU2456880835.USD","BKR","SG9999003800.SGD","LU0170899867.USD","LVS","LU0943347566.SGD","DAL","LU2210149790.SGD","LU0321505439.SGD"],"gpt_icon":0},{"id":"2450726359","title":"BUZZ-辉瑞推进减肥药的举措拖累了一些开发商","url":"https://stock-news.laohu8.com/highlight/detail?id=2450726359","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450726359?lang=zh_cn&edition=full","pubTime":"2024-07-11 20:15","pubTimestamp":1720700140,"startTime":"0","endTime":"0","summary":" (更新)    7月11日 - ** 减肥药开发商Viking Therapeutics   股价盘前下跌4.8%至55.22美元** 辉瑞  计划在今年下半年将其实验性肥胖药danuglipron的改良版、每日一次版推进到临床试验中。** 今年 3 月，VKTX 公司称，其实验性口服药物  在一项小型早期试验中对志愿者进行了测试，结果显示其体重降低了 3.3%。** ALT 和 GPCR 的肥胖症实验药物均已成功完成  中期试验 ** 截至上次收盘，VKTX 的股价上涨了两倍多，ALT 下跌了 33.5%，GPCR 则上涨了 2.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4139","LU1894683348.USD","SG9999002224.SGD","BK4568","LU0122379950.USD","LU0234572021.USD","IE00BLSP4452.SGD","ALT","GPCR","IE00BBT3K403.USD","BK4592","LU1894683264.USD","SG9999001176.SGD","LU0321505439.SGD","LU0321505868.SGD","SG9999003800.SGD","SG9999002232.USD","LU1066051498.USD","VKTX","LU0289739699.SGD","BUZZ","BK4588","BK4581","LU0868494617.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","BK4533","SG9999001176.USD","LU1023059063.AUD","PFE","IE0002270589.USD","SG9999013999.USD","BK4585","LU1883839398.USD","SGXZ57979304.SGD","LU0456855351.SGD","LU1057294990.SGD","BK4550","IE00B19Z3581.USD","SG9999011175.SGD","BK4007","LU0058720904.USD","LU1878469433.USD","LU0170899867.USD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2450358094","title":"BUZZ-辉瑞计划推出日服一次的减肥药，维京人受到冲击","url":"https://stock-news.laohu8.com/highlight/detail?id=2450358094","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450358094?lang=zh_cn&edition=full","pubTime":"2024-07-11 19:15","pubTimestamp":1720696559,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    7月11日 - ** 减肥药开发商Viking Therapeutics   股价盘前下跌4.8%至55.22美元** 辉瑞  表示，它将在今年下半年把其试验性肥胖药danuglipron的改良版、一日一次版推进到临床试验中。** 今年 3 月，VKTX 称其减肥药在一项小型研究中显示 (link)，7 人的体重减轻了 3.3** 礼来公司和诺和诺德公司的热门市场领导者都是皮下注射药物** 截至上一交易日收盘，VKTX公司的股价已上涨两倍多。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","SG9999002224.SGD","LU0058720904.USD","LU0868494617.USD","LU0321505868.SGD","LU1883839398.USD","SG9999001176.SGD","BK4568","SG9999001176.USD","IE00BLSP4452.SGD","SG9999013999.USD","SGXZ57979304.SGD","SG9999003800.SGD","LU0321505439.SGD","LU1066053197.SGD","IE0002270589.USD","LU1066051498.USD","BK4588","BK4533","BK4585","SG9999011175.SGD","LU0234572021.USD","LU0122379950.USD","LU0456855351.SGD","LU1894683264.USD","LU1057294990.SGD","SG9999002232.USD","LU0170899867.USD","BK4581","BK4592","BK4007","BK4550","BK4139","IE00B19Z3B42.SGD","VKTX","LU1894683348.USD","IE00B19Z3581.USD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0289739699.SGD","BK4534","IE00BBT3K403.USD"],"gpt_icon":0},{"id":"2450816371","title":"Viking Therapeutics, Inc.盘中异动 大幅上涨5.02%报56.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450816371","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450816371?lang=zh_cn&edition=full","pubTime":"2024-07-10 22:19","pubTimestamp":1720621176,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日22时19分，Viking Therapeutics, Inc.股票出现异动，股价大幅拉升5.02%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Kazia Therapeutics Limited涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为2663.85%、1067.14%、692.58%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Kazia Therapeutics Limited，振幅分别为119.83%、83.64%、62.50%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102219379681b8ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102219379681b8ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4585","VKTX","BK4588"],"gpt_icon":0},{"id":"2450027941","title":"Viking Therapeutics, Inc.盘中异动 临近午盘大幅上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450027941","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450027941?lang=zh_cn&edition=full","pubTime":"2024-07-09 23:43","pubTimestamp":1720539809,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日23时43分，Viking Therapeutics, Inc.股票出现异动，股价大幅拉升5.00%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.85%。其相关个股中，Soligenix, Inc.、180 Life Sciences Corp.、Uniqure N.V.涨幅较大，Soligenix, Inc.、180 Life Sciences Corp.、Longeveron Inc.较为活跃，换手率分别为9409.07%、840.50%、289.69%，振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为327.50%、96.91%、87.00%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709234329af915eb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709234329af915eb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VKTX","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2448116415","title":"Viking Therapeutics, Inc.盘中异动 大幅下跌5.00%报52.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448116415","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448116415?lang=zh_cn&edition=full","pubTime":"2024-07-03 00:37","pubTimestamp":1719938247,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日00时37分，Viking Therapeutics, Inc.股票出现波动，股价急速跳水5.00%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703003727af903761&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703003727af903761&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","VKTX","BK4585","BK4588"],"gpt_icon":0},{"id":"2448915481","title":"Viking Therapeutics, Inc.盘中异动 大幅拉升5.00%报55.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448915481","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448915481?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:00","pubTimestamp":1719842405,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时00分，Viking Therapeutics, Inc.股票出现波动，股价大幅上涨5.00%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701220005941f2c0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701220005941f2c0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","VKTX","LENZ"],"gpt_icon":0},{"id":"2446524941","title":"美国研究综述-Equity Residential、高盛、Marsh & Mclennan","url":"https://stock-news.laohu8.com/highlight/detail?id=2446524941","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446524941?lang=zh_cn&edition=full","pubTime":"2024-06-28 15:42","pubTimestamp":1719560556,"startTime":"0","endTime":"0","summary":"    路透6月28日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Equity Residential、高盛和 Marsh & Mclennan。要点 * Equity Residential   ：Piper Sandler 将其评级从 \"中性 \"上调至 \"增持\"。* 高盛   ：加拿大皇家银行将目标价从 405 美元上调至 435 美元  * Marsh & Mclennan   ：加拿大皇家银行将目标价从210美元上调至228美元  * Pagerduty Inc   ：丰业银行给予其行业表现评级 * Williams Companies Inc   ：摩根大通将目标价从42美元上调至47美元  以下是路透周五报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","WBA","LU0640476718.USD","LU0689472784.USD","BK4550","DAL","BK4559","HAL","MMC","LBRT","LU0170899867.USD","LU1917777945.USD","LU1162221912.USD","LU0310800965.SGD","RXRX","BP","WMB","GIS","BK4139","CALC","BK4092","BKR","LU1064131342.USD","LU0820561909.HKD","ACCD","NKE","BK4552","LU2023250504.SGD","EQR","LU0149725797.USD","LU1169590202.USD","PUMP","VKTX","LU1430594728.SGD","LU1983260115.SGD","BK4501","GS","IE00B19Z3581.USD","SM","APOG","NINE","GE","PTEN","LU0820562030.AUD","PD","HP","MKC","LU1303367103.USD","BK4558","BK4146"],"gpt_icon":0},{"id":"2446824977","title":"Viking Therapeutics, Inc.盘中异动 大幅下跌5.03%报49.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446824977","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446824977?lang=zh_cn&edition=full","pubTime":"2024-06-26 01:18","pubTimestamp":1719335914,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日01时18分，Viking Therapeutics, Inc.股票出现异动，股价快速下挫5.03%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.41%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。该信息摘要如下：奥本海默控股分析师Jay Olson维持$Viking Therapeutics $买入评级，维持目标价138美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626011835aef68ade&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626011835aef68ade&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","VKTX","LENZ"],"gpt_icon":0},{"id":"2445985737","title":"Viking Therapeutics, Inc.盘中异动 急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445985737","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445985737?lang=zh_cn&edition=full","pubTime":"2024-06-22 01:21","pubTimestamp":1718990463,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日01时21分，Viking Therapeutics, Inc.股票出现异动，股价大幅上涨5.00%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622012103aef60fec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622012103aef60fec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VKTX","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2442315067","title":"Viking Therapeutics, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442315067","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442315067?lang=zh_cn&edition=full","pubTime":"2024-06-11 23:37","pubTimestamp":1718120256,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日23时37分，Viking Therapeutics, Inc.股票出现波动，股价快速下挫5.04%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611233736af8cf75a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611233736af8cf75a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4588","BK4585","VKTX","BK4139"],"gpt_icon":0},{"id":"2441710629","title":"Viking Therapeutics, Inc.盘中异动 早盘快速下挫5.02%报55.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441710629","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441710629?lang=zh_cn&edition=full","pubTime":"2024-06-06 21:38","pubTimestamp":1717681135,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日21时38分，Viking Therapeutics, Inc.股票出现异动，股价急速跳水5.02%。Viking Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Viking Therapeutics, Inc.公司简介：Viking Therapeutics Inc 是一家医疗保健服务提供商。VK2809 和 VK0214 是甲状腺激素受体 β 的口服、组织和受体亚型选择性激动剂。消息层面，截至21时38分，《H.C. Wainwright维持Viking Therapeutics买入评级，维持目标价90美元》资讯为影响Viking Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213856af8c6a80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606213856af8c6a80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VKTX","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2441255087","title":"BUZZ--美国股票走势-Paramount Global、Core Scientific、Amarin","url":"https://stock-news.laohu8.com/highlight/detail?id=2441255087","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441255087?lang=zh_cn&edition=full","pubTime":"2024-06-05 01:46","pubTimestamp":1717523203,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      6月4日 - 在劳动力市场数据加剧了对经济日益疲软的担忧之后，美国股指周二走低，而华尔街一些最受欢迎股票的获利回吐加剧了跌幅。美东时间13:29，道琼斯工业平均指数  上涨0.15%，报38,627.97点。标普500指数  下跌0.14%，报5275.99点；纳斯达克综合指数  下跌0.15%，报16802.806点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVS","AAPL","QID","ALLE","AX","SDOW","BKR","CVX","FSLR",".DJI","INTC","VKTX","XOM","TQQQ","UDOW","ANNX","CNM","FCX","HON","HQY","DXD","GME","PARA","DJX","MNQmain","DVN","PSQ","BBWI","NEM","PARAA","SCCO","CORZ","NQmain",".IXIC","TOL","CRWD","HEI","SPOT","FEAM","BUZZ","GTLB","AMRN","S","BA","PARAP","QLD","SWK","CPB","DDM","DCI"],"gpt_icon":0},{"id":"2441255082","title":"BUZZ--美国股票走势-Paramount Global、Core Scientific、Amarin","url":"https://stock-news.laohu8.com/highlight/detail?id=2441255082","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441255082?lang=zh_cn&edition=full","pubTime":"2024-06-05 01:46","pubTimestamp":1717523203,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      6月4日 - 在劳动力市场数据加剧了对经济日益疲软的担忧之后，美国股指周二走低，而华尔街一些最受欢迎股票的获利回吐加剧了跌幅。美东时间13:29，道琼斯工业平均指数  上涨0.15%，报38,627.97点。标普500指数  下跌0.14%，报5275.99点；纳斯达克综合指数  下跌0.15%，报16802.806点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPL","CVX","DDM","DVN","PARA","PARAA","SPOT","CNM","TOL","CPB","CORZ","INTC","GME","HON","QLD","BA","PSQ","FCX","FSLR","QID","BUZZ","S","VKTX","HEI","TQQQ","CRWD","UDOW","GTLB","BBWI",".DJI",".IXIC","SCCO","HQY","ANNX","SDOW","MNQmain","DCI","PARAP","ALLE","NEM","AX","XOM","DJX","FEAM","BKR","DXD","SWK","AMRN","NQmain","CVS"],"gpt_icon":0},{"id":"2440237277","title":"BUZZ--美国股票走势-Core & Main、HEICO、霍尼韦尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2440237277","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440237277?lang=zh_cn&edition=full","pubTime":"2024-06-04 23:57","pubTimestamp":1717516651,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      6月4日 - 最新的劳动力市场数据加剧了人们对全球最大经济体日益疲软的担忧，标普500指数和纳斯达克指数周二下滑。美东时间11:33，道琼斯工业平均指数  下跌0.15%，报38514.76点。标普500指数  下跌0.42%，报5261.36点；纳斯达克综合指数  下跌0.43%，报16756.272点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UDOW","NEM",".DJI","SQQQ","AMRN","TOL","PARA","SCCO","BBWI","FCX","GME","ALLE","FEAM","DOG","DJX","DDM","BUZZ","DCI","QLD","INTC","SDOW","GTLB","PSQ","MNQmain","NQmain","HON","QID","S","TQQQ",".IXIC","XOM","DVN","ANNX","HQY","SPOT","AAPL","QQQ","HEI","SWK","CORZ","DXD","CNM","BKR",".SPX","VKTX","FSLR","CVS","CVX","AX","BA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vikingtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1098},{"period":"1month","weight":0.0051},{"period":"3month","weight":-0.1974},{"period":"6month","weight":1.3381},{"period":"1year","weight":2.3487},{"period":"ytd","weight":1.7351}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Viking Therapeutics, Inc.于2012年9月24号在特拉华州成立。该公司是一个临床阶段的生物制药公司，致力于开发新的，第一类或最好的新陈代谢和内分泌失调类疗法。该公司拥有全球独家权利基于许可的配体小分子组合在五个候选药物在临床试验或临床前研究。公司的主导临床程序是VK0612，它是进入2b期临床试验为2型全球最大的健康挑战之一的治疗糖尿病疾病口服药物，它在同药物中排列第一。公司的第二临床程序vk5211，可把口服的候选药物送入第二阶段临床试验治疗一种复杂的疾病特点的不受控制的肌肉质量下降癌症恶病。VK5211是一种非甾体选择性雄激素受体调节剂，或SARM。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.031825},{"month":2,"riseRate":0.555556,"avgChangeRate":0.264573},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.020024},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000523},{"month":5,"riseRate":0.3,"avgChangeRate":0.094367},{"month":6,"riseRate":0.4,"avgChangeRate":-0.023196},{"month":7,"riseRate":0.4,"avgChangeRate":-0.016582},{"month":8,"riseRate":0.444444,"avgChangeRate":0.019922},{"month":9,"riseRate":0.333333,"avgChangeRate":0.070513},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.002105},{"month":11,"riseRate":0.555556,"avgChangeRate":0.0115},{"month":12,"riseRate":0.666667,"avgChangeRate":0.206888}],"exchange":"NASDAQ","name":"Viking Therapeutics, Inc.","nameEN":"Viking Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Viking Therapeutics, Inc.(VKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Viking Therapeutics, Inc.(VKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Viking Therapeutics, Inc.,VKTX,Viking Therapeutics, Inc.股票,Viking Therapeutics, Inc.股票老虎,Viking Therapeutics, Inc.股票老虎国际,Viking Therapeutics, Inc.行情,Viking Therapeutics, Inc.股票行情,Viking Therapeutics, Inc.股价,Viking Therapeutics, Inc.股市,Viking Therapeutics, Inc.股票价格,Viking Therapeutics, Inc.股票交易,Viking Therapeutics, Inc.股票购买,Viking Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Viking Therapeutics, Inc.(VKTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Viking Therapeutics, Inc.(VKTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}